Nu Med Plus Inc (NUMD) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jun 30 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nu med Plus Inc   (NUMD)

Nu Med Plus Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Nu Med Plus Inc in the second quarter 2026?
Due to the lack of equity, it was not possible to calculate Nu Med Plus Inc 's return on equity (ROE) in its second quarter 2026

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 0 0 0 0 0
Return On Equity (TTM) - - - - -
NUMD's Total Ranking # # # # #
Equity (TTM) in Millions 0 0 0 0 0
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to NUMD Management Effectiveness >> NUMD's 5 Years Annual ROE >> Compare NUMD ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





NUMD Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 0 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions 0 0 0 0 -1
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

Back to NUMD Management Effectiveness >> NUMD's 5 Years Annual ROE >> Compare NUMD ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
NUMD's' Return on Equity at Yahoo Finance
NUMD's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for NUMD's Competitors
Subscribers only: Roe for Nu Med Plus Inc 's Suppliers
Subscribers only: Return On Equity for NUMD's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE
Corcept Therapeutics Inc  8.27 %
Integer Holdings Corporation  7.43 %
Pacific Health Care Organization Inc  7.42 %
Vericel Corporation  6.91 %
The Cooper Companies Inc   6.90 %
Siga Technologies Inc  6.74 %
Merck and Co Inc   6.59 %
Zimmer Biomet Holdings Inc   6.36 %
National Vision Holdings Inc   5.71 %
Conmed Corporation  5.51 %
Pfizer Inc  4.91 %
Privia Health Group Inc   4.23 %
Becton Dickinson And Company  3.79 %
Alkermes Plc   3.72 %
Lifemd Inc   3.47 %
Lifestance Health Group Inc   3.39 %
Revvity Inc  3.27 %
Bio rad Laboratories Inc   3.15 %
Envista Holdings Corporation  3.08 %
Immucell Corporation  2.68 %
Surgery Partners Inc   2.63 %
Mimedx Group Inc   2.61 %
Cormedix Inc   2.18 %
Atricure Inc   2.14 %
Pacira Biosciences inc   2.13 %
Warby Parker Inc   2.06 %
Repligen Corp  1.98 %
Arvinas Inc   1.91 %
Waters Corporation  1.88 %
Omada Health Inc   1.84 %

Date modified: 2026-08-15T21:33:58+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.